Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 eraArticle Published on 2022-12-012022-11-15 Journal: Microbiological research [Category] [DOI] 10.1016/j.micres.2022.127206 PMC 바로가기
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunizationArticle Published on 2022-11-052022-11-15 Journal: International journal of pharmaceutics [Category] [DOI] 10.1016/j.ijpharm.2022.122256 PMC 바로가기
An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challengesArticle Published on 2022-11-012022-11-15 Journal: Biochemical pharmacology [Category] [DOI] 10.1016/j.bcp.2022.115279 PMC 바로가기
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2Article Published on 2022-10-162022-11-15 Journal: Molecules [Category] [DOI] 10.3390/molecules27206934 PMC 바로가기
A Review: Highlighting the Links between Epigenetics, COVID-19 Infection, and Vitamin DArticle Published on 2022-10-142022-11-16 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.3390/ijms232012292 PMC 바로가기
Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS-CoV-2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticalsArticle Published on 2022-10-012022-11-15 Journal: Journal of food biochemistry [Category] [DOI] 10.1111/jfbc.14262 PMC 바로가기
Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue SyndromeArticle Published on 2022-09-162022-11-16 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.952987 PMC 바로가기
Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide-Development and Validation of the Novel Analytical MethodArticle Published on 2022-08-232022-11-16 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.3390/ijms23179544 PMC 바로가기
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease아니소다민은 시험관 내에서 SARS-CoV-2 감염을 강력하게 억제하고 주요 프로테아제를 표적으로 합니다Article Published on 2022-08-062022-09-11 Journal: Biochemical and Biophysical Research Communication [Category] [DOI] 10.1016/j.bbrc.2022.05.024 PMC 바로가기 [Article Type] Article
Extracardiac Prothrombotic Effects of COVID-19COVID-19의 심장 외 혈전 효과Review Published on 2022-08-012022-09-11 Journal: Cardiology clinics [Category] [DOI] 10.1016/j.ccl.2022.03.008 PMC 바로가기 [Article Type] Review